Intricon, an international joint development manufacturer engaged in designing, developing, engineering, manufacturing, and packaging miniature interventional, implantable and body-worn medical devices, has named Annalee Lutgen as its chief financial officer.

“Annalee will play a critical role on the leadership team and as CFO during this new stage of accelerated growth,” said Scott Longval, Intricon President and CEO. “Annalee knows our business and her proven financial experience in the medical device and high-tech industries is a valuable asset as we continue to expand the company.”

Annalee Lutgen joined Intricon in 2010 as Corporate Controller and has since gained increasing responsibility for the accounting and finance functions of the company, most recently as the Director of Finance. Prior to joining Intricon, Ms. Lutgen was a manager with Grant Thornton.  She is a Certified Professional Accountant and holds an MBA from St. Cloud State University.

Lutgen will oversee financial operations for Intricon, which has more than 900 employees across three offices and six manufacturing sites. Intricon recently transitioned from being a publicly traded corporation to a private company, owned by private equity firm Altaris, whose portfolio consists of growth companies in the health care industry.

“I’m excited to take the position of CFO during this transformational period of the company,” said Lutgen. “IntriCon has a solid track record and great potential for growth. As a team, we’re committed to further growing the company.”